INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Consensus Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
25.99 ^USD	+2.73%		-10.04%	-40.32%

May. 07	Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating	MT
May. 07	Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45	MT

Evolution of the average Target Price on Integra LifeSciences Holdings Corporation

Price target over the last 5 years

History of analyst recommendation changes

6b02e512ff16.i6eB4mT4MVJL2moX_VEoiAkAW2MobvN5eMzMB8F6-7w.-MDjqDC8cCo87ixhrSZN_l5rIlNNA5xND62gSZk3g4j-0rTTAJEJF3-xCQ~5d59aa7e636181973dbded258eea7790

Analyst Recommendations on Integra LifeSciences Holdings Corporation

Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating	May. 07	MT
Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45	May. 07	MT
Oppenheimer Downgrades Integra LifeSciences Holdings to Perform From Outperform	May. 07	MT
North American Morning Briefing : Stock Futures -2-	May. 06	DJ
Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target	Apr. 03	MT
Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target is $38	Apr. 03	MT
Truist Securities Cuts Price Target on Integra LifeSciences Holdings to $41 From $46, Maintains Hold Rating	Mar. 01	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $46 From $44, Maintains Hold Rating	Dec. 22	MT
Truist Adjusts Integra LifeSciences Holdings' Price Target to $44 From $39, Keeps Hold Rating	Dec. 14	MT
Wells Fargo Upgrades Integra LifeSciences to Overweight From Equalweight, Raises Price Target to $49 From $40	Dec. 05	MT
CL King Starts Coverage on Integra LifeSciences With Buy Rating, $50 Price Target	Nov. 14	MT
Morgan Stanley Adjusts Price Target on Integra LifeSciences to $37 From $44, Maintains Underweight Rating	23-10-26	MT
Morgan Stanley Downgrades Integra LifeSciences to Underweight From Equalweight, Price Target is $44	23-08-24	MT
JMP Securities Adjusts Integra LifeSciences Price Target to $60 From $65, Maintains Market Outperform Rating	23-07-28	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $48 From $44, Maintains Hold Rating	23-07-19	MT
Is it game over for inflation?	23-07-12
Jefferies Upgrades Integra LifeSciences to Buy From Hold, Cuts Price Target to $53 From $58	23-07-12	MT
ANALYST RECOMMENDATIONS : Activision Blizzard, AstraZeneca, Citigroup, Microsoft, Model N...	23-07-12
Argus Downgrades Integra LifeSciences Holdings to Hold From Buy	23-06-08	MT
Morgan Stanley Adjusts Price Target on Integra LifeSciences to $43 From $59, Keeps Equalweight Rating	23-05-31	MT
JPMorgan Downgrades Integra LifeSciences to Underweight From Neutral, Adjusts Price Target to $43 From $56	23-05-24	MT
ANALYST RECOMMENDATIONS : AMD, Autodesk, Broadcom, National Grid, Sherwin-Williams...	23-05-24
Citigroup Downgrades Integra LifeSciences Holdings to Sell From Neutral, Adjusts Price Target to $39 From $59	23-05-23	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $54 From $58, Maintains Hold Rating	23-05-18	MT
JMP Securities Adjusts Integra LifeSciences Holdings' Price Target to $65 From $75, Keeps Outperform Rating	23-04-27	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

25.99 USD

Average target price

33.8 USD

Spread / Average Target

+30.05%

High Price Target

51 USD

Spread / Highest target

+96.23%

Low Price Target

24 USD

Spread / Lowest Target

-7.66%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Integra LifeSciences Holdings Corporation

Truist Securities
Oppenheimer
Wells Fargo Securities
Citigroup
CL King
Morgan Stanley
JMP Securities
Jefferies & Co.
Argus
JPMorgan Chase
Piper Sandler
UBS
BofA Securities
Credit Suisse
BTIG

Ratings for Integra LifeSciences Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar